Abstract:Abstract Parkinson’s disease (PD) is an incurable, devastating disorder that is characterized by pathological protein aggregation and neurodegeneration in the substantia nigra. In recent years, growing evidence has implicated the gut environment and the gut-brain axis in the pathogenesis and progression of PD, especially in a subset of people who exhibit prodromal gastrointestinal dysfunction. Specifically, perturbations of gut homeostasis are hypothesized to contribute to α-synuclein aggregation in enteric neurons, which may spread to the brain over decades and eventually result in the characteristic central nervous system manifestations of PD, including neurodegeneration and motor impairments. However, the mechanisms linking gut disturbances and α-synuclein aggregation are still unclear. A plethora of research indicates that toll-like receptors (TLRs), especially TLR2 and TLR4, are critical mediators of gut homeostasis. Alongside their established role in innate immunity throughout the body, studies are increasingly demonstrating that TLR2 and TLR4 signalling shapes the development and function of the gut and the enteric nervous system. Notably, TLR2 and TLR4 are dysregulated in patients with PD, and may thus be central to early gut dysfunction in PD. To better understand the putative contribution of intestinal TLR2 and TLR4 dysfunction to early α-synuclein aggregation and PD, we critically discuss the role of TLR2 and TLR4 in normal gut function as well as evidence for altered TLR2 and TLR4 signalling in PD, by reviewing clinical, animal model and in vitro research. Growing evidence on the immunological aetiology of α-synuclein aggregation is also discussed, with a focus on the interactions of α-synuclein with TLR2 and TLR4. We propose a conceptual model of PD pathogenesis in which microbial dysbiosis alters the permeability of the intestinal barrier as well as TLR2 and TLR4 signalling, ultimately leading to a positive feedback loop of chronic gut dysfunction promoting α-synuclein aggregation in enteric and vagal neurons. In turn, α-synuclein aggregates may then migrate to the brain via peripheral nerves, such as the vagal nerve, to contribute to neuroinflammation and neurodegeneration typically associated with PD.

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?

Gut brain axis: an insight into microbiota role in Parkinson’s disease

Neuroimmune Connectomes in the Gut and Their Implications in Parkinson's Disease

Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease

The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options

The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease

The Gut-Brain Axis in the Pathogenesis of Parkinson’s Disease

The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease

The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options

Inflammation and immune dysfunction in Parkinson disease

The Role of Gut Dysbiosis in Parkinson's Disease: Mechanistic Insights Andtherapeutic Options.

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease

Intestinal Inflammation and Parkinson’s Disease

The interplay between gut microbiota and the brain-gut axis in Parkinson's disease treatment

The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic

Intestinal Inflammation and Parkinson's Disease.

Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson's Disease: A Review of Inflammatory Markers and Potential Effects

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut

Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease